Page 44 - மருத்துவ ஆய்வகம் முன்னேற்றம் திருத்தங்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

This lab is helping fight the STI testing shortage caused by COVID-19 Share Article MicroGenDX is a PCR and NGS lab with its own lab developed test (LDT) and is not impacted by the same shortages that are causing delays in STI testing elsewhere. MicroGenDX Logo MicroGenDX has over 11 years’ experience designing, and validating laboratory developed tests and mitigating risk in supply chains so that we are able to run the test you need when you need it. ORLANDO, Fla. (PRWEB) December 21, 2020 In an era when shortages abound, having options is invaluable. Worldwide, labs are facing a scarcity of supplies, as those needed to test for diseases such as sexually transmitted infections (STIs) must be diverted to Covid-19 testing. Enter MicroGenDX, a company specializing in qPCR + Next Generation Sequencing (NGS) microbial molecular diagnostics.a company that designs and set up its own tests and multiplex panels in-ho

United statesNick sanfordCenters for diseaseCollege of american pathologyClinical laboratory improvement amendmentsCollege of american pathologistsLab developed testClinical laboratory improvements amendmentsNext generation sequencingDisease controlSection directorAmerican pathologyProstate testingAmerican pathologistsPolymerase chain reactionNext generation